TeleClinic GmbH

TeleClinic GmbH is a German telemedicine platform that enables patients to consult licensed physicians through video appointments, enhancing access to healthcare services across the country. Founded in 2015, TeleClinic GmbH is headquartered in Munich, Germany, and specializes in telemedical consultations. The company has successfully completed 3 deals to date, with the most recent funding round being a Series A amounting to EUR 7. 000 mn led by Idinvest Partners on July 16, 2020.

The current valuation of the company stands at EUR 32. 753 mn. The CEO, Max Müller, has been integral to the company's direction since its inception. TeleClinic offers a comprehensive telemedicine platform that facilitates virtual consultations with licensed physicians in Germany via video appointments.

Patients can quickly consult doctors for symptom assessments, prescriptions, and sick notes, all initiated through the TeleClinic app. This service targets patients needing timely medical advice without the constraints of physical appointments, thereby addressing healthcare accessibility effectively. TeleClinic's revenue model relies on telemedical consultations, with costs generally covered by statutory health insurance for eligible patients. Private patients can seek reimbursement for their visits.

The platform operates on a direct-to-consumer basis, generating revenue from transaction structures including per-visit fees for patients opting for services beyond their insurance coverage. This includes electronic prescriptions and sick notes, enhancing the service portfolio. Following the acquisition by Zur Rose Group AG in July 2020, TeleClinic plans to leverage its innovative telemedicine solutions to expand its offerings. The company aims to launch new features aimed at enhancing patient engagement and healthcare accessibility.

Future growth strategies also include targeting expansion into additional European markets, details of which will be developed in alignment with the company's ongoing strategic objectives.